Hydroxymethylation as a Novel Environmental Biosensor

Current environmental health reports

Volumn 1, Issue 1, 2014, Pages

  Dao, T ^a   Cheng, R Y S ^b   Revelo, M P ^c   Mitzner, W ^a   Tang, W Y ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

5 Carboxylmethylcytosine; 5 Formylmethylcytosine; 5 Hydroxymethylcytosine; 5 Methylcytosine; Base excision repair; Deamination; Demethylation; DNA hydroxymethylation; DNA methylation; Environmental biosensor; Environmental health; Epigenetics; Glucosylation; Oxidation; Ten eleven translocation proteins

Indexed keywords

EID: 84906883954     PISSN: None     EISSN: 21965412     Source Type: Journal    
DOI: 10.1007/s40572-013-0005-5     Document Type: Review

References (56)

1. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(3):245–54.
2. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457–63.
3. Pfeifer GP, Kadam S, Jin SG. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin. 2013;6(10):1–9.
4. Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011;25(23):2436–52.
5. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004;32(14):4100–8.
6. Delatte B, Fuks F. TET proteins: on the frenetic hunt for new cytosine modifications. Brief Funct Genomics. 2013;12(3):191–204.
7. Kristensen LS, Treppendahl MB, Grønbæk K. Analysis of epigenetic modifications of DNA in human cells. Curr Protoc Hum Genet. 2013;77:20.2.1–20.2.22.
8. Costello JF, Plass C. Methylation matters. J Med Genet. 2001;38(5):285–303.
9. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in hammalian DNA by MLL partner TET1. Science. 2009;324(5929):930–5. This study demonstrated the discovery of the TET proteins, which catalyze the oxidation of 5-methylcytosine to 5-hydroxymethylation in mammalian DNA. This breakthrough suggested a novel mechanism of regulation of DNA methylation.
10. Thomson JP, Moggs JG, Wolf CR, Meehan RR, Epigenetic profiles as defined signatures of xenobiotic exposure. Mutat Res Genet Toxicol Environ Mutagen. 1–22, Aug. 2013.
11. Wu H, Zhang Y. Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells. Cell Cycle. 2011;10(15):2428–36.
12. Zhao H, Chen T. Tet family of 5-methylcytosine dioxygenases in mammalian development. J Human Genet. 2013;58(7):421–7.
13. Williams K, Christensen J, Helin K. DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep. 2011;13(1):28–35.
14. Thomson JP, Hunter JM, Lempiainen H, Muller A, Terranova R, Moggs JG, et al. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res. 2013;41(11):5639–54.
15. Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D, et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012;22(3):467–77.
16. Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development. 2012;139(11):1895–902.
17. Wanunu M, Cohen-Karni D, Johnson RR, Fields L, Benner J, Peterman N, et al. Discrimination of methylcytosine from hydroxymethylcytosine in DNA molecules. J Am Chem Soc. 2011;133(3):486–92.
18. Yildirim O, Li R, Hung J-H, Chen PB, Dong X, Ee L-S, et al. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell. 2011;147(7):1498–510.
19. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19(1):17–30.
20. Chia N, Wang L, Lu X, Senut M, Brenner C, Ruden DM. Environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics. 2011;6(7):853–6.
21. Morera S, Imberty A, Aschke-Sonnenborn U, Ruger W, Freemont PS. T4 phage beta-glucosyltransferase: substrate binding and proposed catalytic mechanism. J Mol Biol. 1999;292(3):717–30.
22. Song C-X, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. 2011;29(1):68–72.
23. Bhattacharyya S, Yu Y, Suzuki M, Campbell N, Mazdo J, Vasanthakumar A, et al. Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. Nucleic Acids Res. 2013;41(16):e157.
24. Chen L, Zhang L, Zhang L, Cai C. Analysis of global deoxyribonucleic acid 5-hydroxymethylcytosine in tissue by liquid chromatography-tandem mass spectrometry. Se Pu. 2012;30(5):533–7.
25. Gomez C, Pozo OJ, Diaz R, Sancho JV, Vilaroca E, Salvador JP, et al. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses. J Chromatogr A. 2011;1218(29):4727–37.
26. Mao W, Hu J, Hong T, Xing X, Wang S, Chen X, et al. A convenient method for selective detection of 5-hydroxymethylcytosine and 5-formylcytosine sites in DNA sequences. Org Biomol Chem. 2013;11(21):3568–72.
27. Zhang L, Zhang L, Zhou K, Ye X, Zhang J, Xie A, et al. Simultaneous determination of global DNA methylation and hydroxymethylation levels by hydrophilic interaction liquid chromatography-tandem mass spectrometry. J Biomol Screen. 2012;17(7):877–84.
28. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 2010;38(19):e181.
29. Yu M, Hon GC, Szulwach KE, Song C-X, Jin P, Ren B, et al. Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat Protoc. 2012;7(12):2159–70.
30. Yu M, Hon GC, Szulwach KE, Song C-X, Zhang L, Kim A, et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. 2012;149(6):1368–80. This technique could differentiate 5-mC and 5-hmC at a single-base resolution and could be applied for detection of either locus-specific or genome-wide 5-hydroxymethylation.
31. Olkhov-Mitsel E, Bapat B. Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med. 2012;1(2):237–60.
32. Tan L, Xiong L, Xu W, Wu F, Huang N, Xu Y, et al. Genome-wide comparison of DNA hydroxymethylation in mouse embryonic stem cells and neural progenitor cells by a new comparative hMeDIP-seq method. Nucleic Acids Res. 2013;41(7):e84.
33. Yin R, Mao S-Q, Zhao B, Chong Z, Yang Y, Zhao C, et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc. 2013;135(28):10396–403.
34. Minor EA, Court BL, Young JI, Wang G. Ascorbate induces ten-eleven translocation (tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem. 2013;288(19):13669–74.
35. Blaschke K, Ebata KT, Karimi MM, Zepeda-Martínez JA, Goyal P, Mahapatra S, et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013;500(7461):222–6. This study investigates the role of vitamin C in regulating TET activity and DNA methylation profiles in mouse embryonic stem cells.
36. Thomson JP, Lempiäinen H, Tefferi A, Nestor CE, Müller A, Bolognani F, et al. Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol. 2012;13(10):R93.
37. Jefferson WN, Chevalier DM, Phelps JY, Cantor AM, Padilla-Banks E, Newbold RR, et al. Persistently altered epigenetic marks in the mouse uterus after neonatal estrogen exposure. Mol Endocrinol. 2013;27(10):1666–77.
38. Coulter JB, O'Driscoll CM, Bressler JP. Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (Tet1) 5-methylcytosine dioxygenase. J Biol Chem. 2013;288(40):28792–800.
39. Shang Y, Das S, Rabold R, Sham JS, Mitzner W, Tang W-Y. Epigenetic alterations by DNA methylation in house dust mite-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2013;49(2):279–87.
40. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS ONE. 2012;7(7):e41036.
41. Liu C, Liu L, Chen X, Shen J, Shan J, Xu Y, et al. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS ONE. 2013;8(5):e62828.
42. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150(6):1135–46.
43. Gambichler T, Sand M, Skrygan M. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma. Melanoma Res. 2013;23(3):218–20.
44. Huang H, Jiang X, Li Z, Li Y, Song CX, He C, et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110(29):11994–9.
45. Liu X, Guangsen Z, Yi Y, Xiao L, Pei M, Liu S, et al. Decreased 5-hydroxymethylcytosine levels are associated with TET2mutation and unfavorable overall survival in myelodysplastic syndromes. Leuk Lymphoma. 2013;54(11):2466–73.
46. Wang F, Yang Y, Lin X, Wang JQ, Wu YS, Xie W, et al. Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum Mol Genet. 2013;22(18):3641–53.
47. Sierksma ASR, Prickaerts J, Chouliaras L, Rostamian S, Delbroek L, Rutten BPF, et al. Behavioral and neurobiological effects of prenatal stress exposure in male and female APPswe/PS1dE9 mice. Neurobiol Aging. 2013;34(1):319–37.
48. Dong E, Gavin DP, Chen Y, Davis J. Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry. 2012;2:e159.
49. Selgrade MK, Blain RB, Fedak KM, Cawley MA. Potential risk of asthma associated with in utero exposure to xenobiotics. Birth Defect Res C Embryo Today. 2013;99(1):1–13.
50. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 2011;71(24):7360–5.
51. Tefferi A, Thiele J, Vardiman JW. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009;115(17):3842–7.
52. Branco MR, Ficz G, Reik W. Uncovering the role of 5‐hydroxymethylcytosine in the epigenome. Nat Rev Genet. 2011;13(1):7–13.
53. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature. 2010;468(7325):839–43.
54. Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012;151(7):1417–30.
55. Della Sala G, Pizzorusso T. Synaptic plasticity and signaling in Rett syndrome. Dev Neurobiol. Aug. 2013.
56. Grayson DR, Guidotti A. The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology. 2013;38(1):138–66.